---
title: "Report: Novo Nordisk and Hims plan to announce a partnership as early as next Monday, with Novo Nordisk selling weight loss drugs on the Hims platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278184242.md"
description: "Novo Nordisk plans to sell weight loss drugs on the Hims platform, with an announcement of the partnership expected as early as next Monday, ending the legal dispute between the two companies. Previously, Novo Nordisk unilaterally terminated the agreement reached last year because Hims did not stop selling generic drugs"
datetime: "2026-03-07T00:35:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278184242.md)
  - [en](https://longbridge.com/en/news/278184242.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278184242.md)
---

# Report: Novo Nordisk and Hims plan to announce a partnership as early as next Monday, with Novo Nordisk selling weight loss drugs on the Hims platform

According to informed sources, Novo Nordisk plans to sell its weight loss medication on the Hims & Hers Health Inc. platform, thereby ending a highly publicized dispute between the two companies that escalated into legal action last month. The anonymous source stated that Novo Nordisk and Hims may announce a new partnership as early as next Monday. The two companies had reached a similar agreement last year, but Novo Nordisk unilaterally terminated the agreement after Hims refused to stop marketing and selling generic versions of the medication. (Bloomberg)

### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md)

## Related News & Research

- [Key facts: Novo Nordisk India rivals; 7.8k job cuts; less lean mass loss](https://longbridge.com/en/news/283077841.md)
- [Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development](https://longbridge.com/en/news/282636425.md)
- [Health Rounds: Novo Nordisk weight-loss drug shows liver benefits in mouse study](https://longbridge.com/en/news/282732630.md)
- [Why Is Hims & Hers Stock Soaring After FDA's Announcment?](https://longbridge.com/en/news/282988297.md)
- [Novo Nordisk Expands Workforce After Deep Cuts](https://longbridge.com/en/news/283036289.md)